SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001935979-23-000046
Filing Date
2023-07-28
Accepted
2023-07-28 16:35:28
Documents
13
Period of Report
2023-07-27
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K bhvn-20230727.htm   iXBRL 8-K 23665
2 EX-99.1 exhibit991-julybusinessupd.htm EX-99.1 17944
  Complete submission text file 0001935979-23-000046.txt   177862

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20230727.xsd EX-101.SCH 1922
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20230727_lab.xml EX-101.LAB 24801
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20230727_pre.xml EX-101.PRE 13045
7 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20230727_htm.xml XML 2802
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Ltd. (Filer) CIK: 0001935979 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41477 | Film No.: 231123624
SIC: 2834 Pharmaceutical Preparations